Virginia Commonwealth University

VCU Massey Cancer Center

Agenda

9-9:20 a.m. 

Welcome and introductions
Michael Rao, Ph.D., president of Virginia Commonwealth University and VCU Health System; and Gordon D. Ginder, M.D., director, hematologist-oncologist and cancer researcher at VCU Massey Cancer Center

9:20-10:20 a.m. 

Keynote address: Pancreatic cancer
David Ryan, M.D., chief of hematology and oncology and clinical director at the Dana-Farber Cancer Institute, will offer the first keynote address on advancements in caring for patients with pancreatic cancer and the use of adjuvant chemotherapy to treat pancreatic cancer.

10:20-10:30 a.m. Break
10:30-11 a.m.

Tackling melanoma
Andrew Poklepovic, M.D., will present an update on the treatment of patients with metastatic melanoma and discuss the future of molecularly targeted therapy and immunotherapy.

11-11:30 a.m.

Tackling colorectal cancers
Khalid Matin, M.D., will talk about the changing landscape of systemic therapy for colorectal cancers and challenging cases requiring a multi-modality approach. 

11:30 a.m.-12 p.m. 

Tackling glioblastoma multiform—investigator-initiated trials in neuro-oncology
Mark Malkin, M.D., will discuss the unique challenges of treating primary and metastatic brain tumors and explain the rationale behind investigator-initiated clinical trials that address these challenges.

12-1 p.m.

Lunch and round table discussions
Participants can choose to participate in one of the round table discussions listed below, or they can simply take a lunch break. Complimentary box lunches will be provided and there are a variety of seating areas where participants can eat lunch.

  • Familial cancer
  • Massey clinical trials
  • Patient-provider communication for clinical research
  • Precision medicine
  • Survivorship/supportive care
  • The impact of healthcare reform on oncology practice
1-2 p.m.

Keynote address: Acute myeloid leukemia
Richard Stone, M.D., director of the adult leukemia program at the Dana-Farber Cancer Institute, will offer the afternoon keynote address on acute myeloid leukemia, including understanding the standard of care, novel treatment strategies and targeted therapies.

2-2:10 p.m. Break
2:10-2:40 p.m.

Tackling myelodysplastic syndrome
John McCarty, M.D., will discuss the treatment of patients with myelodysplastic syndrome. 

2:40-3:10 p.m.

Tackling amyloidosis
Beata Holkova, M.D., will present on amyloidoses, including how to better understand different subtypes of amyloidosis, recognizing various clinical presentations and increasing familiarity with potential therapies for each amyloidosis subtype. 

3:10-3:40 p.m.

Tackling mantle cell lymphoma and double hit B-cell lymphoma
Danielle Shafer, D.O., will talk about recent advances and novel therapeutic strategies in the management of mantle cell lymphoma as well as the therapeutic challenges of double-hit lymphoma. 

3:40-3:55 p.m.

Closing remarks
Gordon D. Ginder, M.D.

Symposium registration button